Brevel
Brevel is an Israeli food-tech company that uses a proprietary illuminated fermentation platform to produce microalgae-based protein, Chlorella biomass (Purallis™), and lipids for food, nutraceutical, and cosmetics manufacturers, while licensing the platform to fermentation-based product developers.
- Company typePrivate
- Founded2017
- HeadquartersShekef, Israel
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Brevel does
Brevel Ltd. is an Israeli food-technology company founded in 2017 in Tel Aviv (now headquartered in Kiryat Gat) that produces microalgae-based ingredients via a proprietary "illuminated fermentation" platform — the only commercial-scale process globally that integrates internal LED lighting with controlled fermentation in bioreactors to drive photosynthesis in microalgae and other light-dependent organisms. The platform yields what Brevel describes as 100x the output of traditional microalgae cultivation at claimed 90%+ lower cost and 1/100 the environmental footprint, producing a non-GMO Chlorella vulgaris biomass containing up to 87% protein with full amino-acid profile, flavor and color neutrality, and 95% solubility at neutral pH.
Brevel monetizes this platform across three product lines: Brevel Protein (functional microalgae protein ingredient for food manufacturers), Purallis™ (broken-cell Chlorella vulgaris biomass for nutraceutical, supplement, functional food, pharma, and cosmetics applications), and Brevel Lipids (plant-based lipids for food, cosmetics, and biomaterials). It also licenses the illuminated fermentation platform and provides manufacturing services at scales from 3.5L to 5,000L+ to third parties developing fermentation-based products (e.g., Coffeesai for coffee cell culture, Ayana Bio for plant cell culture). The go-to-market is B2B enterprise sales to food and beverage manufacturers, channeled through direct offtake agreements, co-development partnerships with regional exclusivity (e.g., Vgarden for plant-based cheese in Australia), and strategic manufacturing joint ventures (Kibbutz Yotvata, joint owner of the Yotvata Dairy Plant with Strauss).
The company was founded by three Golan brothers — Yonatan (CEO), Matan (COO), and Ido (CTO) — and has raised approximately $25M in total seed funding across 2022–2025, supplemented by non-dilutive grants from EU Horizon 2020, the European Innovation Council, the Israel Innovation Authority, and the U.S.-Israel BIRD Foundation. It holds FSSC 22000, HACCP, Kosher, Halal, and Non-GMO certifications and won the Fi Global Startup Innovation Challenge for Most Innovative Plant-Based or Alternative Ingredient in 2022.
Brevel firmographics
Firmographics- Name
- Brevel
- Legal name
- Brevel Ltd.
- Website
- https://brevel.co.il
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Brevel is an Israeli food-tech company that uses a proprietary illuminated fermentation platform to produce microalgae-based protein, Chlorella biomass (Purallis™), and lipids for food, nutraceutical, and cosmetics manufacturers, while licensing the platform to fermentation-based product developers.
- Ownership category
- akta.pro rank
Brevel industry classification
Industry- Product category
- Alternative Protein Ingredients
- NAICS
- Starch and Vegetable Fats and Oils Manufacturing (31122)
- SIC
- Food And Kindred Products (2000)
- akta.pro primary industry
- Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation) (AFAKAGAH)
- akta.pro secondary industry
- Fermentation-Derived Proteins (Precision Fermentation, Biomass Fermentation) (AFAJAHAH)
Keywords
Where Brevel is headquartered
LocationHeadquarters
- HQ city
- Shekef
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
Brevel business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Infrastructure, Personnel, Marketing or Sales, Supply Chain
Revenue model
- Microalgae Protein Ingredients: Brevel sells its microalgae-based protein ingredients to food and beverage manufacturers for use in plant-based products. Revenue comes from ingredient supply agreements with offtake commitments. The protein is sold as a functional ingredient for dairy alternatives, egg replacements, and other plant-based food applications.
- Purallis™ Chlorella Products: Sale of Purallis™ broken-cell Chlorella vulgaris biomass for nutraceutical, supplement, and functional food applications. Year-round stable supply with consistent nutritional profile.
- Platform Licensing & Manufacturing Services: Brevel licenses its illuminated fermentation technology platform and provides manufacturing services to partners developing fermentation-based products (e.g., Coffeesai for coffee cell culture, Ayana Bio for plant cell culture). Partners validate processes and scale to commercial volumes using Brevel's infrastructure.
- Co-development & Strategic Partnerships: Joint product development with food companies like Vgarden for plant-based cheese containing Brevel protein. Revenue from co-development agreements and eventual commercial supply.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B ingredient pricing for microalgae protein |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
Brevel product offering
Product offeringCore offering
Brevel produces microalgae-based protein ingredients (Brevel Protein, Purallis™ Chlorella biomass, Brevel Lipids) using its proprietary illuminated fermentation platform, which combines internal LED lighting with industrial-scale bioreactor fermentation. The company supplies these B2B ingredients to food, beverage, nutraceutical, cosmetic, and pharmaceutical manufacturers, and licenses its fermentation platform to companies developing light-dependent cell culture products.
Product overview
Brevel offers a portfolio of microalgae-based products powered by its proprietary Illuminated Fermentation Platform. The platform combines light and fermentation in industrial-scale bioreactors, enabling production of three main products: Brevel Protein (microalgae protein ingredient), Purallis™ (broken cell Chlorella vulgaris biomass), and Brevel Lipids (plant-based lipids). The platform technology enables cost-effective, sustainable protein production that is flavor and color neutral, addressing the alternative protein market for food, nutraceutical, pharmaceutical, cosmetics, and wellness applications.
Differentiator
Problem solved
Functional benefit
Brands
- Purallis™: Broken cell Chlorella vulgaris biomass produced via illuminated fermentation, marketed as a pure, uncompromised profile for optimal functionality in supplements, food and beverage, functional nutrition, wellness, pharma, beauty, and biomaterials.
- Brevel Protein
- Brevel Lipids
Products and services
- Brevel Protein Microalgae-based protein ingredient that is flavor and color neutral with high functionality, suitable for food applications including dairy alternatives, egg replacements, and protein-enriched formulations. Produced using illuminated fermentation.
- Purallis™ Broken-cell Chlorella vulgaris biomass produced via illuminated fermentation, marketed for supplements, functional foods, beverages, wellness, pharmaceutical, and biomaterials applications. Rich in protein, vitamins, minerals, antioxidants, and chlorophyll.
- Brevel Lipids High-quality plant-based lipids produced via the Brevel illuminated fermentation platform, suitable for food, cosmetics, wellness, pharma, and biomaterials applications, offering consistent and scalable production with sustainable processes.
- Illuminated Fermentation Platform Scalable illuminated fermentation technology platform with end-to-end capabilities from 3.5L to 5000L scale, offered via licensing and contract manufacturing services to partners developing fermentation-based products using light-dependent organisms such as coffee and plant cell cultures.
Quantifiable outcome
- 90%+ cost reduction in microalgae production vs traditional methods
- +6 more outcomes
Companies that use Brevel
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Brevel technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Brevel partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- CoffeesaicorePartnership to deploy Brevel's illuminated fermentation platform for enhancing coffee cell culture production. Case study validates platform's ability to achieve high cell densities and continuous growth in coffee cell cultures with potential for flavor enhancement. Represents climate-resilient alternative to traditional coffee agriculture.
- Ayana BiocoreJoint research project with $1.25M grant from Israel's BIRD Foundation to research whether Brevel's illuminated fermentation technology can enhance plant cell culture production. Ayana Bio (spinoff from Ginkgo Bioworks) will use Brevel's scalable LED lighting systems in bioreactors. Target commercial scale by 2026, focusing on sage-derived rosmarinic acid.
- VgardencoreStrategic collaboration to develop plant-based cheese and additional food products containing Brevel protein. Vgarden manufactures Brevel-enriched cheeses in Northern Israel for global markets including Australia, US, UK, and Western Europe (2023 launch). Vgarden has exclusivity for Brevel protein in Australia for cheese products.
- YotvatacoreBrevel and Kibbutz Yotvata signed MOU to build commercial-scale manufacturing facility for microalgae-based protein. Facility features 30,000L reactors (largest of their kind) with 900,000L/year capacity. Yotvata, which runs Yotvata Dairy Plant in joint ownership with Strauss, contributes manufacturing expertise and infrastructure. Brevel provides all technology, know-how, and intellectual property.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Brevel competitors and assessment
Company assessmentBroad incumbents
- Beyond Meat: Plant-based protein consumer brand using pea protein as a primary ingredient. Comparable as a major demand-side consumer of alternative proteins and a key reference customer for B2B protein ingredient suppliers like Brevel.
- Impossible Foods: Plant-based meat manufacturer producing finished consumer products, including soy/leghemoglobin protein. Comparable as a downstream alternative-protein buyer/supplier competing for the same plant-based food ingredient customers Brevel sells into.
- Ginkgo Bioworks: Synthetic biology platform company programming microorganisms for industrial applications across food, cosmetics, and pharma. Comparable as a horizontal biomanufacturing platform with cell engineering capabilities overlapping Brevel's fermentation platform.
Direct peers
- Cyanotech: Public microalgae producer (spirulina, BioAstin astaxanthin) operating commercial-scale cultivation in Hawaii. Comparable as a vertically integrated microalgae biomass producer serving nutraceutical and functional food customers.
- Ayana Bio: Plant cell culture company (spun out of Ginkgo Bioworks) producing bioactive compounds via fermentation. Directly comparable as a partner using Brevel's illuminated platform — competes in adjacent plant-cell-cultured ingredient space.
- Perfect Day: Precision fermentation leader producing animal-free whey protein via fermentation. Directly comparable to Brevel as a B2B fermentation-derived protein ingredient supplier targeting food manufacturers, with a similar cost-down, scale-up trajectory.
- Corbion: Global ingredient company with a dedicated microalgae platform (AlgaPrime™) supplying DHA and omega-3 ingredients into feed and food. Most directly comparable large-scale microalgae B2B ingredient supplier competing for the same customer wallets as Brevel.
Regional players
- Solar Biotech: Biomanufacturing CDMO operating fermentation infrastructure for partners. Comparable as a fermentation-platform service provider offering scale-up and manufacturing services analogous to Brevel's platform licensing model.
Emerging players
- Triton Algae Innovations: Specialty microalgae ingredient company developing protein and nutraceutical ingredients from proprietary strains. Comparable emerging microalgae ingredient supplier targeting food and supplement applications.
- AlgaeBiologics (AlgaeBio): Emerging microalgae ingredient company producing Chlorella and other strains for food, nutraceutical, and aquafeed markets. Comparable as a microalgae biomass competitor targeting overlapping nutraceutical and food customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Brevel social profiles
Digital presenceBrevel compliance and trust
Trust signalCompliance5 records
Brevel financial estimates
Financial estimateRevenue estimate
Valuation estimate
Brevel leadership team
Management profileNumber of profiles
Profiles1 record
Brevel funding detail
Funding detailFunding overview
Funding rounds12 records
Investors16 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Brevel M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Brevel
What does Brevel do?
Brevel produces microalgae-based protein ingredients (Brevel Protein, Purallis™ Chlorella biomass, Brevel Lipids) using its proprietary illuminated fermentation platform, which combines internal LED lighting with industrial-scale bioreactor fermentation. The company supplies these B2B ingredients to food, beverage, nutraceutical, cosmetic, and pharmaceutical manufacturers, and licenses its fermentation platform to companies developing light-dependent cell culture products.
Is Brevel a public or private company?
Brevel is a private company. It is classified as venture growth investor backed and is currently operating.
When was Brevel founded?
Brevel was founded in 2017. It employs 11 to 50 people.
Where is Brevel based?
Brevel is headquartered in Shekef, Israel, in the Middle East region.
How does Brevel make money?
Four revenue lines are on record. Microalgae Protein Ingredients are the primary driver. The others are purallis™ Chlorella Products, platform Licensing & Manufacturing Services and co-development & Strategic Partnerships.
Who are Brevel's main competitors?
Broad incumbents on record are Beyond Meat, Impossible Foods and Ginkgo Bioworks. Direct peers are Cyanotech, Ayana Bio, Perfect Day and Corbion. Solar Biotech is listed as a regional player. Emerging players are Triton Algae Innovations and AlgaeBiologics (AlgaeBio).
Does Brevel have an API?
No public API is recorded for Brevel.
What industry is Brevel in?
Brevel's product category is Alternative Protein Ingredients. Its primary akta.pro industry code is AFAKAGAH, Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation), with a secondary code of AFAJAHAH, Fermentation-Derived Proteins (Precision Fermentation, Biomass Fermentation). Its NAICS code is 31122 and its SIC code is 2000.